Pheochromocytoma
📧 Sign up to get email alerts when something new happens for Pheochromocytoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-01-21Clinical Trial Update: 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System [Phase 2]
The Phase 2 trial evaluating the radiopharmaceutical 18F-mFBG for neural crest tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-11Clinical Trial Update: 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma
This clinical trial evaluating 131I-MIBG therapy for relapsed/refractory neuroblastoma is no longer available; sponsored by UT Southwestern …
-
CLINICAL_TRIALS withdrawal · 2015-12-21Clinical Trial Update: Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma [Phase 1]
The Phase I trial of vandetanib in combination with 131I-mIBG for advanced pheochromocytoma and paraganglioma has been withdrawn.